GENERAL COMMENTS
The present study aimed to clarify the utility of international consensus diagnostic criteria (ICDC) for autoimmune pancreatitis (AIP) by comparing its diagnostic performance with those of other previous criteria of HISORt and Asian criteria, and concluded that ICDC has better diagnostic performance compared to previous proposed diagnostic criteria, in both diffuse and focal type AIP. I agree the results of the present study. Though authors stressed that this article is the first study to determine the diagnostic accuracy of ICDC of AIP from pancreatic cancer with focus on "focal" type AIP, other some studies already showed identical results. It is necessary to refer these previous studies and show new findings. This study focused on only type 1 AIP, however, study participant seemed to be not typical one with respect to gender and age. Major 1. This is not the first study to determine the diagnostic accuracy of ICDC of AIP from pancreatic cancer. Please check at least following previous studies. Could you show new findings compared with these previous studies?
(1) K. Sumimoto, K. Uchida, T. Mitsuyama et al., "A proposal of a diagnostic algorithmwith validation of international consensus diagnostic criteria for autoimmune pancreatitis in a Japanese cohort," Pancreatology, vol. 13, no. 3, pp. 230-237, 2013. (2) I. Naitoh, T. Nakazawa, K. 
Thsi paper is well written. However, some similar papers have been already published. Strongness of this paper is that number of cases is high as a single center. Please decide accept or reject according to the status of this journal.
However, as ICDC were made on basis of the experience of HISORt's and Asian criteria, superiority of ICDC is not surprising. Weakness of ICDC is too complex.
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GENERAL COMMENTS
Because the ICDC was proposed to standardize the diagnostic criteria worldwide, this kind of study from different countries (Taiwan, in this case) is important. The strength of this study is the first study from Taiwan to compare the diagnostic power of different diagnostic criteria for AIP. I have several suggestions to further increase the scientific merit of the study. Major 1. Although the authors state that this is the first study to determine the diagnostic accuracy of ICDC from pancreatic cancer with focus on "focal" type AIP, there have been similar studies especially from Japan (Ikeuta T, et al. Pancreas 2013; Maruyama, Gastroenterol Res Pract. 2013, etc) . Basically, this study confirms the previous reports showing that ICDC is superior to HiSORt and Asian criteria. The text should be revised to correctly describe these situations.
2. The title does not clearly state the study. Although the title states that this study focuses on the differential diagnosis, the text did not focus on the differential diagnosis. Indeed, the ICDC were intended to diagnose AIP accurately and not to differentially diagnose AIP from pancreatic cancer. These points should be clearly stated. 
Major This paper compared the diagnostic accuracy in the diagnosis of AIP in a Taiwan cohort and confirmed the previous reports that the ICDC is the most sensitive and accuracy among the previous diagnostic criteria. In this meaning, there are not informative and a little worth as an original article. However, as AIP cases in Taiwan can be compared in the world, these data can be submitted as letter to the editor.
Minor 1) There have been some reports regarding comparison of the ICDC and other previous major criteria. These should be cited and discussed.
2) There are some typographical errors. (eg. In line 18 on page 19, "ad" should be "and". In the line 22 on page25, "The are" should be "There are"
VERSION 1 -AUTHOR RESPONSE
Response to the Reviewer : Name Shigeyuki Kawa Institution and Country Center for Health, Safety and Environmental Management, Shinshu University Japan Major 1. Thanks for the expertise comments. We had made corrections and revisions to address that our study is the first one in Taiwan (abstract: page3, line 4; article focus : page 5, line 11 an d 12; article summary: page6, line 9 and 11). Besides, we had add description and result regarding the comparison of different criteria in Japanese with adding citations (Discussion, page 20, the last 3 lines, labeled by yellow color; references 15,16,17,18) as your suggestion. 2. Thank you for the comment. Though ICDC is considered to be superior to other various criteria, ICDC seems to be too complicated to handle for clinician. However, owing to type 1 AIP is still composed of a heterogeneous population, at his time moment, we did not have suitable simple amendment for ICDC for clinical use in our country. With the advance of better understanding the pathogenesis of the disease, to simplify the diagnostic criteria might be feasible and needed for clinician. We had made revision for this comment in the Discussion section to address this issue (page 20. Last line and page 21, line 1-6) 3. Thank you for the comment. We used HISORt criteria after 2006, and also used Asian after 2008 before ICDC established. However, we did not have our own diagnostic criteria before 2006. We add description regarding this issue in the article (.page8, line 13-15) 4. Thank you for the comment. In analyzing our data, we also noticed that the male gender was not markedly dominantly in our study population and the age seemed younger than other series in other countries. However, the study participants were consecutively collected in our prospective cohort of pancreatitis. The age and gender distribution were not different compared to our previous published smaller series of AIP. We also examined whether these type 1 AIP patient also fit the criteria for type2. However, patient enrolled in this study could only fit type 1 criteria but not type 2. We will keep attention for this issue in our maintained cohort. 5. Thank you for the comment. The mean serum IgG4 level of pancreatic cancer was 119.2±23.9 mg/dL, which seems to be higher compared to previous reports. The distribution IgG4 level was wide.
We had an article (in minor revision) to address the role of IgG 4 in differentiating type 1AIP and pancreatic cancer) which will focus on the serological criteria.
Response to the Reviewer :Name Terumi Kamisawa Institution and Country Department of Internal Medicine Tokyo Metropolitan KOmagome Hospital, Tokyo, Japan
Thank you for the comments. We had made corrections and revisions to address that our study is the first one in Taiwan (abstract: page3, line 4; article focus : page 5, line 11 an d 12; article summary: page6, line 9 and 11). Besides, we had add description and result regarding the comparison of different criteria in Japanese with adding citations (Discussion, page 20, the last 3 lines, labeled by yellow color; references 15, 16, 17, 18) One major problem of ICDC is too complex for general practice .We had made revision for this comment in the Discussion section to address this issue (page 20. Last line and page 21, line 1-8) Response to the Reviewer :Name Atsushi Masamune Institution and Country Tohoku University Graduate School of Medicine, Japan
